Proteins that fold into the wrong shapes are piling up inside cells, and this research aims to measure exactly how and why that happens. Proteins must fold into precise three-dimensional shapes to function, but they sometimes misfold and clump together into toxic aggregates. This process drives dozens of devastating conditions, including Alzheimer’s, Parkinson’s, type 2 diabetes, and prion diseases. Despite decades of work, researchers still lack a quantitative, predictive understanding of how cells maintain the balance between healthy and aberrant protein states—a balance known as protein homeostasis. This project brings together chemists, nanoscientists, geneticists, and clinicians to build that understanding from the ground up. The team will combine experiments and theory to map the full range of protein states—from partially folded intermediates to amyloid fibrils—and measure how fast they form and convert into one another. Nanoscience techniques will link aggregation rates to the mechanical properties of amyloid structures, while fruit fly models will test whether theoretical predictions hold in living animals. If successful, this fundamental science will provide a rational framework for designing therapies that prevent or reverse protein misfolding. It will not deliver a drug tomorrow, but it could transform how researchers approach diseases that currently have no cure.
View original technical description
The ability of all living systems to function requires a high level of regulation of the behaviour of proteins, which are the molecules that are involved in essentially all the biochemical reactions taking place within them. Proteins usually carry out their functions by adopting specific conformations, known as native states, which are encoded in their amino acid sequences. Much research in molecular biology has therefore been focused on the properties of native states of proteins. It is increasingly evident, however, that non-native states of proteins also play a fundamental role in determining the normal development of cellular activities. A variety of diseases, which include systemic conditions such as type II diabetes and dialysis-related amyloidosis, and neurodegenerative conditions such as Alzheimer's, Parkinson's and the various prion diseases, have been identified that are associated with the incorrect folding of proteins and their subsequent aggregation. Very considerable efforts, including much work by our own research groups, have been devoted in the last several years to addressing these problems by enhancing our ability of understanding the behaviour of proteins, including folding, misfolding and assembly. The approach that we propose in this application is based on two realisations. The first is that the investigation of protein homeostasis provides a general framework to formulate a comprehensive description of the behaviour of proteins in the cell. The second is that major advances can now be made by exploiting the opportunities offered by technical and conceptual developments that have taken place in disciplines such nanoscience, chemistry and neurobiology. We have thus brought together researchers from these disciplines that have already an established track record of successful collaborations to put forward an ambitious programme or research with the goal of increasing the level at which we can understand rationally and quantitatively the outcome of cellular processes. More specifically, we propose to carry out research at the Department of Chemistry (Prof Dobson and Dr Vendruscolo) to achieve a detailed determination, by a combination of experiment and theory, of the multiple possible states of proteins, including partially folded conformations, misfolding intermediates, amyloid fibrils, as well as of the pathways of their interconversion. The activity at the Nanoscience Centre (Prof Welland) will be devoted to the use of nanoscience techniques to establish quantitative relationships between different aspects of protein behaviour, including their aggregation rates and the mechanical properties of amyloid structures. Finally, at the Departments of Genetics (Dr. Crowther) and of Medicine (Prof Lomas) we will use in vivo Drosophila models in conjunction with theoretical predictions to enhance our understanding of the physico-chemical origin of misfolding diseases and to explore the development of rational strategies for their treatment.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know